Shopping Cart
- Remove All
- Your shopping cart is currently empty
MI-2 (Menin-MLL Inhibitor) is an effective menin-MLL interaction inhibitor (IC50: 446 ± 28 nM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $228 | Backorder | |
10 mg | $313 | Backorder | |
25 mg | $690 | Backorder |
Description | MI-2 (Menin-MLL Inhibitor) is an effective menin-MLL interaction inhibitor (IC50: 446 ± 28 nM). |
In vitro | In HEK293 cells, MI-2 accessed the protein target menin-MLL and effectively inhibited the menin-MLL-AF9 interaction. MI-2 effectively blocked cell proliferation, and induced cell apoptosis in human MLL leukemia cell lines harboring different MLL translocations MLL-AF9 and MLL-ENL, with the GI50 value of about 5 μM for MI-2. MI-2 showed little effect on the cell growth of E2A-HLF transduced BMC with the GI50 of > 50 μM. MI-2 specifically reduced the immortalization potential of cells transformed with MLL fusion oncoproteins by downregulating the expression of target genes required for MLL fusion protein oncogenic activity [1]. |
In vivo | After 7 days of treatment with MI-2, MLL-AF9 transformed BMC showed great morphology changes and the expression of CD11b was greatly increased [1]. |
Molecular Weight | 448.5 |
Formula | C18H25N5S2·2HCl |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO: 10 mg/mL Ethanol: ≤30 mg/mL |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.